Puerarin Alleviates Experimental Autoimmune Thyroiditis by Regulating Macrophages

作者：Qing Tao, Yu Chen, Liang Qiao, Jianfeng Shi, Zhiguo Wang, Haiyan Min, Qian Gao, Xiaoming Yao, Lei Wang · 发表于：The Journal of Immunology · 年份：2024 · DOI：10.4049/jimmunol.2300779 · 被引用次数：14 · 研究领域：Stress Responses and Cortisol、Thyroid Disorders and Treatments、Growth Hormone and Insulin-like Growth Factors

Hashimoto's thyroiditis (HT) is the most common organ-specific autoimmune disease, predominantly affecting women. Although the pathogenesis of HT is incompletely understood, some studies have found that macrophage polarization plays a role. Puerarin is a soy isoflavone compound that has anti-inflammatory and immunomodulatory effects and regulates macrophage immune activity. This study aimed to verify the therapeutic effect of puerarin on HT and explored its regulatory effect on macrophage polarization imbalance in HT. Through bioinformatics analysis and molecular biology methods, it was found that macrophages increased significantly in HT patients and model mice. Immunological staining showed that puerarin intervention could reduce tissue inflammatory cell infiltration. Molecular biological examination displayed that puerarin could inhibit local and systemic inflammation levels, and the expression of marker thyroglobulin and thyroid peroxidase Abs. In vivo experimental results indicated that puerarin regulated macrophage polarity and reduced inflammatory damage, possibly by inhibiting the pyroptosis signaling pathway. In vivo macrophage clearance experiments demonstrated that puerarin relied on macrophages to exert its mechanism of action in treating HT. The results of this study indicate that macrophages are important mediators in the development of HT, and puerarin can regulate macrophage polarity and inflammatory status to provide thyroid tissue protection, which provides ...